Dibenzene derivatives as calcium channel blockers
Details for Australian Patent Application No. 2006325232 (hide)
International Classifications
Event Publications
24 July 2008 PCT application entered the National Phase
PCT publication WO2007/068754 Priority application(s): WO2007/068754
3 December 2009 Amendment Made
The nature of the amendment is: Amend the applicant name from Neuropharma, S.A. to Noscira, S.A. 2007
12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006325236-Methods for obtaining immortalized antibody secreting cells
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser